Strikingly, the endothelial cells in the brain lesions in patients with MS have been found to express reduced levels of PD-L2, suggesting that the disease may be associated with a defect in PD-L2-mediated regulation [26]. The gene discussed is PDCD1LG2; the disease is myeloid sarcoma.